Amedisys Inc (AMED)
NASDAQ:AMED

Amedisys (AMED) Stock Forecast & Price Target

417 Followers
See the Price Targets and Ratings of:

AMED Analyst Ratings

Moderate Buy
13Ratings
7 Buy
5 Hold
1 Sell
Based on 13 analysts giving stock ratings to
Amedisys
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AMED Stock 12 Months Forecast

Average Price Target

$124.00
▲(43.60% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Amedisys in the last 3 months. The average price target is $124.00 with a high forecast of $150.00 and a low forecast of $88.00. The average price target represents a 43.60% change from the last price of $86.35.
Highest Price Target$150.00Average Price Target$124.00Lowest Price Target$88.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Raymond James
Hold
Downgraded
Credit Suisse, Meta Platforms, Wolfspeed And Some Other Big Stocks Moving Lower On ThursdayAmedisys, Inc. AMED fell 14.4% to $90.19 after the company reported worse-than-expected Q3 results. Raymond James downgraded the stock from Outperform to Market Perform.
Jefferies
$150.00
Buy
73.71%
Upside
Reiterated
Amedisys (AMED) Gets a Buy from Jefferies
Benchmark Co.
$135.00
Buy
56.34%
Upside
Reiterated
Amedisys price target lowered to $135 from $165 at BenchmarkAmedisys price target lowered to $135 from $165 at Benchmark
Bank of America Securities
$102.00
Sell
18.12%
Upside
Downgraded
B of A Securities Downgrades Amedisys to Underperform, Lowers Price Target to $102
Credit Suisse
$182.00
Buy
110.77%
Upside
Reiterated
Amedisys (AMED) PT Raised to $182 at Credit SuisseCredit Suisse analyst A.J. Rice raised the price target on Amedisys (NASDAQ: AMED) to $182.00 (from $181.00) while maintaining a Outperform rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

AMED Financial Forecast

AMED Earnings Forecast
Next quarter’s earnings estimate for AMED is $0.99 with a range of $0.87 to $1.04. The previous quarter’s EPS was $1.15. AMED beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.48% of the time in the same period. In the last calendar year AMED has Outperformed its overall industry.
Next quarter’s earnings estimate for AMED is $0.99 with a range of $0.87 to $1.04. The previous quarter’s EPS was $1.15. AMED beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.48% of the time in the same period. In the last calendar year AMED has Outperformed its overall industry.
AMED Sales Forecast
Next quarter’s sales forecast for AMED is $560.43M with a range of $554.65M to $572.14M. The previous quarter’s sales results were $557.99M. AMED beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year AMED has Underperformed its overall industry.
Next quarter’s sales forecast for AMED is $560.43M with a range of $554.65M to $572.14M. The previous quarter’s sales results were $557.99M. AMED beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year AMED has Underperformed its overall industry.
AMED Analyst Recommendation Trends
In the current month, AMED has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AMED average analyst price target in the past 3 months is $124.00
In the current month, AMED has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AMED average analyst price target in the past 3 months is $124.00

AMED Stock Forecast FAQ

What is AMED’s average 12-month price target, according to analysts?
Based on analyst ratings, Amedisys’s 12-month average price target is $124.00.
    What is AMED’s upside potential, based on the analysts’ average price target?
    Amedisys has 43.60% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is AMED a Buy, Sell or Hold?
          Amedisys has a conensus rating of Moderate Buy which is based on 7 buy ratings, 5 hold ratings and 1 sell ratings.
            What is Amedisys’s price target?
            The average price target for Amedisys is $124.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $150.00 ,the lowest forecast is $88.00. The average price target represents 43.60% Increase from the current price of $86.35.
              What do analysts say about Amedisys?
              Amedisys’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis